-
3
-
-
0034687072
-
Placebo-controlled trials and active-controlled trials in the evaluation of new treatments. Part 1: Ethical and scientific issues
-
Temple R, Ellenberg SS. Placebo-controlled trials and active-controlled trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Int Med 2000; 133:455-63.
-
(2000)
Ann Int Med
, vol.133
, pp. 455-463
-
-
Temple, R.1
Ellenberg, S.S.2
-
4
-
-
0035819920
-
Scientific and ethical issues in equivalence trials
-
Djulbegovic B, Clarke M. Scientific and ethical issues in equivalence trials. JAMA 2001;285:1206-8.
-
(2001)
JAMA
, vol.285
, pp. 1206-1208
-
-
Djulbegovic, B.1
Clarke, M.2
-
8
-
-
0242670541
-
Class and equivalence
-
Class and equivalence. Bandolier 2001;95:3-5.
-
(2001)
Bandolier
, vol.95
, pp. 3-5
-
-
-
9
-
-
0035159999
-
Active-control equivalence trials and antihypertensive agents
-
McAlister FA, Sackett DL. Active-control equivalence trials and antihypertensive agents. Am J Med 2001;111:553-8.
-
(2001)
Am J Med
, vol.111
, pp. 553-558
-
-
McAlister, F.A.1
Sackett, D.L.2
-
10
-
-
1842837960
-
Princípios de análise metodológica de ensaios terapêuticos. Part I: Validade dos resultados
-
Soares I, Carneiro AV. Princípios de análise metodológica de ensaios terapêuticos. Part I: Validade dos resultados. Rev Port Cardiol 2002;21:457-69.
-
(2002)
Rev Port Cardiol
, vol.21
, pp. 457-469
-
-
Soares, I.1
Carneiro, A.V.2
-
11
-
-
0022640774
-
Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
-
Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
-
(1986)
Lancet
, vol.1
, pp. 397-402
-
-
-
12
-
-
0036616447
-
Princípios básicos da análise metodológica de ensaios terapêuticos. Parte III: Aplicabilidade dos resultados ao doente individual
-
Soares I, Carneiro AV. Princípios básicos da análise metodológica de ensaios terapêuticos. Parte III: Aplicabilidade dos resultados ao doente individual. Rev Port Cardiol 2002; 21:783-95.
-
(2002)
Rev Port Cardiol
, vol.21
, pp. 783-795
-
-
Soares, I.1
Carneiro, A.V.2
-
13
-
-
0035901579
-
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
-
Altman DG, Schulz KF, Moher D, et al. for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Int Med 2001;134:663-94.
-
(2001)
Ann Int Med
, vol.134
, pp. 663-694
-
-
Altman, D.G.1
Schulz, K.F.2
Moher, D.3
-
14
-
-
0033578116
-
Baseline imbalance in randomised controlled trials
-
Roberts C, Torgerson D. Baseline imbalance in randomised controlled trials. BMJ 1999;319:185.
-
(1999)
BMJ
, vol.319
, pp. 185
-
-
Roberts, C.1
Torgerson, D.2
-
15
-
-
0028849245
-
Subverting randomization in controlled trials
-
Schulz KF. Subverting randomization in controlled trials. JAMA 1995;274:1456-8.
-
(1995)
JAMA
, vol.274
, pp. 1456-1458
-
-
Schulz, K.F.1
-
16
-
-
17144460768
-
Glossário de termos e conceitos utilizados pela cardiologia baseada na evidência científica. Part II: Ensaios clínicos
-
Carneiro AV. Glossário de termos e conceitos utilizados pela cardiologia baseada na evidência científica. Part II: Ensaios clínicos. Rev Port Cardiol 2001;20:203-10.
-
(2001)
Rev Port Cardiol
, vol.20
, pp. 203-210
-
-
Carneiro, A.V.1
-
18
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
-
CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
19
-
-
0036868809
-
Marcadores de doença cardíaca em ensaios clínicos
-
Carneiro AV, Costa J. Marcadores de doença cardíaca em ensaios clínicos. Rev Port Cardiol 2002;21:1349-60.
-
(2002)
Rev Port Cardiol
, vol.21
, pp. 1349-1360
-
-
Carneiro, A.V.1
Costa, J.2
-
20
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindhohn LH, Nieminen MS, Omvik P, Oparil S, Wedel H, for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlöf, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
Julius, S.4
Beevers, G.5
Faire, U.6
Fyhrquist, F.7
Ibsen, H.8
Kristiansson, K.9
Lederballe-Pedersen, O.10
Lindhohn, L.H.11
Nieminen, M.S.12
Omvik, P.13
Oparil, S.14
Wedel, H.15
-
21
-
-
0025942936
-
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
-
Dahlöf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
-
22
-
-
0034709738
-
Seeing what you want to see in randomized controlled trials: Versions and perversions of UKPDS data
-
McCormack J, Greenhalgh T. Seeing what you want to see in randomized controlled trials: versions and perversions of UKPDS data. BMJ 2000;320:1720-3.
-
(2000)
BMJ
, vol.320
, pp. 1720-1723
-
-
McCormack, J.1
Greenhalgh, T.2
-
23
-
-
0032694404
-
Design issues in noninferiority/equivalence trials
-
Hwang IK, Morikawa T. Design issues in noninferiority/equivalence trials. Drug Information J 1999;33:1205-18.
-
(1999)
Drug Information J
, vol.33
, pp. 1205-1218
-
-
Hwang, I.K.1
Morikawa, T.2
-
26
-
-
0003689967
-
-
Philadelphia: Lippincott Williams and Wilkins
-
Designing clinical research. Philadelphia: Lippincott Williams and Wilkins, 2001.
-
(2001)
Designing Clinical Research
-
-
|